Neuromuscular Exercises Improve Shoulder Function More Than Standard Care Exercises in Patients With a Traumatic Anterior Shoulder Dislocation:A Randomized Controlled Trial by Eshoj, Henrik Rode et al.
 
  
 
Aalborg Universitet
Neuromuscular Exercises Improve Shoulder Function More Than Standard Care
Exercises in Patients With a Traumatic Anterior Shoulder Dislocation
A Randomized Controlled Trial
Eshoj, Henrik Rode; Rasmussen, Sten; Frich, Lars Henrik; Hvass, Inge; Christensen, Robin;
Boyle, Eleanor; Jensen, Steen Lund; Søndergaard, Jens; Søgaard, Karen; Juul-Kristensen,
Birgit
Published in:
Orthopaedic Journal of Sports Medicine
DOI (link to publication from Publisher):
10.1177/2325967119896102
Creative Commons License
CC BY-NC-ND 4.0
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Eshoj, H. R., Rasmussen, S., Frich, L. H., Hvass, I., Christensen, R., Boyle, E., Jensen, S. L., Søndergaard, J.,
Søgaard, K., & Juul-Kristensen, B. (2020). Neuromuscular Exercises Improve Shoulder Function More Than
Standard Care Exercises in Patients With a Traumatic Anterior Shoulder Dislocation: A Randomized Controlled
Trial. Orthopaedic Journal of Sports Medicine, 8(1), [2325967119896102].
https://doi.org/10.1177/2325967119896102
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Original Research
Neuromuscular Exercises Improve Shoulder
Function More Than Standard Care
Exercises in Patients With a Traumatic
Anterior Shoulder Dislocation
A Randomized Controlled Trial
Henrik Rode Eshoj,*† PhD, Sten Rasmussen,‡§ MD, PhD, Lars Henrik Frich,||{ MD, PhD,
Inge Hvass,# MD, PhD, Robin Christensen,**†† PhD, Eleanor Boyle,* PhD,
Steen Lund Jensen,‡‡ MD, PhD, Jens Søndergaard,§§ MD, PhD, Karen Søgaard,*{ PhD,
and Birgit Juul-Kristensen,*|||| PhD
Investigation performed at University of Southern Denmark, Odense, Denmark
Background: There is an important gap in knowledge about the effectiveness of nonoperative treatment (exercise) for patients
with traumatic primary and recurrent anterior shoulder dislocations (ASDs).
Purpose/Hypothesis: The purpose of this study was to assess the efficacy and safety of physical therapist–supervised, shoulder
instability neuromuscular exercise (SINEX) versus self-managed, home-based, standard care shoulder exercise (HOMEX) in
patients with traumatic ASDs. The hypothesis was that SINEX would have a larger effect and fewer adverse events compared with
HOMEX.
Study Design: Randomized controlled trial; Level of evidence, 2.
Methods: A total of 56 participants with radiographically verified, trauma-initiated primary or recurrent ASDs and self-reported
decreased shoulder function were randomized to 12 weeks of either SINEX or HOMEX. The SINEX program consisted of 7
exercises, individually progressing from basic (2 20 repetitions each day) to elite (2 10 repetitions, 3 times weekly). The HOMEX
program included 5 shoulder exercises performed 3 times weekly (2  10 repetitions). The primary outcome was the Western
Ontario Shoulder Instability Index (WOSI) score, ranging from 0 (best possible) to 2100. The between-group minimal clinically
important difference at 12 weeks was 250 points. Secondary outcomes included WOSI subdomain scores, patient-reported
ratings of kinesiophobia and pain, objective shoulder function, patient satisfaction, and number of adverse events.
Results: The between-group mean difference in the WOSI total score at 12 weeks significantly favored SINEX over HOMEX (–228.1
[95% CI, –430.5 to –25.6]). SINEX was furthermore superior to HOMEX in most of the secondary outcomes (3/4 subdomains of the
WOSI and pain level during the past 7 days as well as clinical signs of anterior shoulder instability). Also, although not statistically
significant, less than half the proportion of the SINEX patients compared with the HOMEX patients (3/27 [11%] vs 6/24 [25%],
respectively; P ¼ .204) underwent or were referred for shoulder stabilizing surgery. Satisfaction with both exercise programs was
high, and no serious adverse events were reported.
Conclusion: Neuromuscular shoulder exercise (SINEX) was superior to standard care exercise (HOMEX) in patients with traumatic
ASDs. Further long-term follow-ups on treatment effects are needed.
Registration: NCT02371928 (ClinicalTrials.gov identifier).
Keywords: shoulder; traumatic; instability; neuromuscular exercise; physical therapy
A traumatic anterior shoulder dislocation (ASD) is a com-
mon athletic injury among young, active patients.34 The
annual incidence of primary traumatic ASDs is between
11.2 and 26.2 per 100,000 people.30,32,52 Patients with pri-
mary traumatic ASDs are prone to recurrent ASDs because
The Orthopaedic Journal of Sports Medicine, 8(1), 2325967119896102
DOI: 10.1177/2325967119896102
ª The Author(s) 2020
1
This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (https://creativecommons.org/
licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are
credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For article reuse guidelines, please visit SAGE’s website at
http://www.sagepub.com/journals-permissions.
of lesions of the glenoid labrum, an important stabilizer of
the shoulder.31,42 This may lead to recurrent ASDs and
symptoms for longer periods,3 reduced participation in
physical activity, and decreased shoulder-related quality
of life.16,37,44
Diverging strategies exist as to the optimum treatment for
this group. For young, active male patients with primary
traumatic ASDs, 2 systematic reviews have concluded that
shoulder stabilizing surgery with postsurgical shoulder
rehabilitation was superior to nonsurgical standard care
treatment only in reducing the risk of recurrent ASDs.19,34
These systematic reviews included 4 randomized controlled
trials (RCTs) with rehabilitation of only primary traumatic
ASDs,5,22,27,50 and these studies had several limitations: lim-
ited description of the rehabilitation protocol and lack of
short-term treatment effect measures. Moreover, the pri-
mary endpoint was objectively registered anterior shoulder
redislocation, which usually does not occur until 12 to 24
months after a primary traumatic ASD.40 Therefore, from
RCTs, little is known about patients with primary and recur-
rent traumatic ASDs on short-term and subjective outcomes
of shoulder symptoms and function.25
Furthermore, in qualitative, cross-sectional, and cohort
studies, it was reported that many patients (*50%) with a
primary traumatic ASD who had been treated nonsurgi-
cally did not experience recurrent ASDs, whereas shoulder
function in general was poor.21 Also, it was reported that
some patients who were treated with surgery and rehabil-
itation reported poor shoulder function, a fear of reinjuries,
and unstable shoulders for long periods.16,44 This would
tend to indicate that nonsurgical standard care treatment
is only suboptimal and that initial surgery is not ideal for
all patients with traumatic ASDs (primary or recurrent). In
addition, as not all patients are candidates for surgery (sur-
geon’s or one’s own decision), an efficient and evidence-
based standardized physical therapy regimen for the
nonsurgical management of traumatic ASDs is needed.
Such a regimen has not yet been established, as also seen
in treatment recommendations within this area, which are
only weakly substantiated as described because of the
absence of RCT studies that compare the effect of nonsur-
gical exercise programs.25 Traditionally, nonsurgical stan-
dard care treatment for patients with traumatic ASDs
consists of closed reduction followed by immobilization in
a shoulder sling, and, if provided, some type of physical
therapy (eg, shoulder range of movement exercises and low
load strengthening of the rotator cuff muscles).5,22,27 How-
ever, as a traumatic ASD often leads to loss of mechanical
stability and deficits to the global neuromuscular and pro-
prioceptive systems, in addition to weakness of the rotator
cuff muscles,9,10,20,29,43 a greater focus on neuromuscular
exercises that enhance compensatory functional shoulder
stability may seem relevant. While other studies on
patients with traumatic knee instability (anterior cruciate
ligament tears) have shown a large effect for progressive
neuromuscular exercise programs,11,17 such programs do
not exist for patients with traumatic ASDs.53 This is why
it seems reasonable to also develop and evaluate treatment
effects of such a program for patients with traumatic
ASDs.36
Therefore, the purpose of this RCT was to evaluate the
efficacy and safety of a nonsurgical, supervised, progressive
shoulder instability neuromuscular exercise (SINEX) pro-
gram compared with a self-managed, home-based, stan-
dard care shoulder exercise program (HOMEX) in
patients with traumatic ASDs. The hypothesis was that
SINEX would (1) have a larger effect than HOMEX and
(2) not induce more adverse events than HOMEX.
METHODS
Trial Design
A multicenter, randomized, assessor-blinded, controlled
clinical superiority trial was conducted using a parallel
(1:1) group design. All patients gave written informed con-
sent, and the study fulfilled the principles of the Declara-
tion of Helsinki.51 The study conformed to the CONSORT
2010 statement.41 Details of the trial design and methods
have been published elsewhere.15 The statistical analysis
plan is provided as supplementary material (see Appendix
1, available as supplemental material). Deviations to the
study protocol15 were as follows: Initially, patients had to
have clinical signs of anterior shoulder instability with pos-
itive findings on a minimum of 2 of 3 clinical tests (appre-
hension, relocation, surprise). However, this criterion was
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removed from inclusion criteria because many of the
patients reported poor shoulder function without having
clinical signs of anterior shoulder instability. However, the
clinical tests were retained as treatment effect measures.
Furthermore, the objective measurement of prone-lying
shoulder stability (using a Nintendo Wii Balance Board),
originally included in the objective outcome test battery,15
was withdrawn because of low concurrent validity com-
pared with the gold standard (force platform).14
Setting and Participants
Patients were recruited from 3 orthopaedic shoulder units
in the Regions of Southern and Northern Denmark from
March 2015 to March 2017, with the final deadline for
enrollment set at March 31, 2017.15 Eligible patients were
men and women between the ages of 18 and 39 years with
trauma-initiated, unidirectional anterior shoulder instabil-
ity.18 Inclusion criteria were radiographically verified acute
primary or recurrent ASDs (using a radiograph that showed
the actual dislocation, which is standard procedure before
manual reduction in Denmark) and self-reported decreased
ability to perform shoulder movements during daily activi-
ties in the previous 7 days. Patients were assessed for eligi-
bility to participate in the RCT within 3 to 6 weeks after
their current shoulder injury. This screening window was
chosen to ensure that all patients had completed initial
immobilization of the shoulder after reduction. Exclusion
criteria were humeral head fractures and/or bony Bankart
lesions requiring early surgery (evaluated by orthopaedic
surgeons), prior surgery in the affected shoulder joint, more
than 5 ASDs in the patient’s lifetime, suspected competing
diagnoses (such as rheumatoid arthritis, cancer, neurologi-
cal disorders, fibromyalgia, psychiatric diseases), sensory
and motor deficits in the neck and shoulder, current preg-
nancy, inability to speak or write Danish, and/or inability to
attend 12 weeks of supervised shoulder training.
Stratified Randomization and Blinding
Patients were randomly assigned to either SINEX or
HOMEX with a 1:1 allocation per study site, stratified
according to injury status: that is, a primary (first-time) or
recurrent (second- to fifth-time) ASD. A computer-generated
randomization sequence was produced using PROC PLAN
(SAS Institute) to generate the schedules before any patient
was enrolled, allocating patients in permuted blocks of 2, 4,
or 6 to the SINEX or HOMEX program. At each trial site,
these (stratified) lists were sequentially numbered in opa-
que, concealed envelopes. A total of 2 outcome assessors,
blinded to treatment allocation, performed all measure-
ments according to procedures described previously.15
Interventions
As standard care treatment varies, the HOMEX program
was developed to reflect the core similarity of standard care
packages while still representing a realistic treatment
option. The SINEX program was developed to accommodate
shoulder mechanical loss and proprioceptive impairment
subsequent to trauma-initiated primary or recurrent
ASDs.9,10,20,29,43
SINEX Program. A cornerstone of the neuromuscular
exercises was movement quality through guided supervi-
sion from physical therapists. The neuromuscular exercises
included strength, coordination, balance, and propriocep-
tion, which were integrated simultaneously into various
body positions, enhancing compensatory functional shoul-
der stability. This is in contrast with the standard care
program (HOMEX) that relied primarily on strength train-
ing to increase muscle mass. The SINEX group received 12
weeks of individually tailored, supervised sessions of pro-
gressive shoulder exercise in addition to functional kinetic
chain exercise. The SINEX program included 7 exercises
targeting the glenohumeral and scapular muscles. Each
exercise has 7 progression levels (basic to elite), with exer-
cises at the basic level performed every day (2  20 repeti-
tions) and exercises at the elite level performed 3 times
weekly (2  10 repetitions). Exercises followed general
strength training principles, with basic and elite levels refer-
ring to low and high load exercises. All patients in the
SINEX group had access to online exercise instructions and
videos through the physical therapy website (digifys.com).
Supervised sessions were provided throughout the 12
weeks, lasting approximately 45 minutes each. Supervised
sessions were offered twice a week for the first 2 weeks and
then once a week for the remaining 10 weeks, summing up to
a maximumof 14 sessions. The amountof supervised sessions
needed was decided byphysical therapistsbased onthe move-
ment control and capability of the individual patient. How-
ever, to satisfactorily complete the SINEX program,
attendance of at least 7 (50%) supervised sessions (of
14 possible) was required in addition to completion of at least
two-thirds (66%) of the planned home-based exercises (self-
reported training diary). A full description of the SINEX pro-
gram is provided as supplementary material (see Appendix 2,
available as supplemental material).
HOMEX Program. The HOMEX group received 1 intro-
ductory supervised physical therapy session, including a
leaflet with photographs and descriptions of exercises.
Patients were instructed not to perform exercises that
exceeded their pain limit and that provoked shoulder pain.
The HOMEX program consisted of active exercises for the
rotator cuff and scapular muscles using elastic bands and 1
exercise for mobility/coactivation of the scapular and core
stability muscles. Patients had to perform the exercises for
12 weeks, 3 times weekly (2  10 repetitions). After 6
weeks, patients received a telephone call from a physical
therapist to ascertain the appropriate progression of and
compliance with the exercises. Compliance with the
HOMEX program was reached, with a minimum of two-
thirds (66%) of the planned home training completed (via
self-reported training diary). Further details of the
HOMEX program are provided as supplementary material
(see Appendix 3, available as supplemental material).
Outcome Measures
The primary endpoint was the change in the total score of
the patient-reported Western Ontario Shoulder Instability
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Index (WOSI) from baseline to the 12-week follow-up. The
WOSI covers 21 items, each ranging from 0 to 100, with
higher scores representing worse shoulder-related quality
of life.26 A reliable and validated Danish version of the
WOSI was used.12
Secondary patient-reported outcomes were the sub-
domain scores (physical symptoms, sport function, lifestyle,
emotions) of the WOSI collected at baseline and weeks 4, 8,
and 12. Further secondary patient-reported outcome mea-
sures included the Tampa Scale of Kinesiophobia,35,47 the
EuroQol 5-Dimensions questionnaire,38 and the Patient-
Specific Functional Scale7 as well as pain intensity now,
average pain intensity in the past 24 hours, and average
pain intensity in the previous 7 days using the Numeric
Pain Rating Scale (NPRS).8 Objective secondary outcome
measures included the Constant-Murley score (CMS),
including the CMS subdomains of range of motion and iso-
metric shoulder abduction strength (in kg) with the use of a
dynamometer,2 blindfolded shoulder joint reposition sense
(JRS) testing within low ranges of shoulder flexion and
abduction (0 to 60 ± 10) with the use of a laser beam,45
and clinical tests for anterior shoulder instability13 as well
as the Beighton score for the classification of generalized
joint hypermobility.4,24 Patients further reported their
impression of recovery at week 12 using the global per-
ceived effect (GPE) scale and responded to questions on
exercise-related adverse events and other shoulder-
related issues after participation.
Statistical Analysis
To reduce bias in the interpretation of the primary out-
come, a blinded interpretation framework was used (see
Appendix 4, available as supplemental material).23 All
analyses followed the intention-to-treat (ITT) principle;
missing data were replaced using nonresponder imputation
(ie, baseline observation carried forward technique)33
because of the assumption that those who dropped out
returned to their baseline WOSI score (ie, null imputation).49
Simple descriptive statistics of either group means with
standard deviations or within-group numbers and propor-
tions were used. Change values were calculated, and
results are presented as the estimated adjusted between-
group mean difference of change values, besides adjusted
risk differences, with 95% CIs and associated P values.
Analysis of covariance (ANCOVA) was used to analyze the
mean change and self-reported data of continuous out-
comes, presented as estimates of least squares means with
95% CIs. The model included treatment group, study cen-
ter, sex, and injury status (primary or recurrent ASD) as
fixed effects, adjusting each patient’s dependent outcome
for his or her baseline score, with baseline as a covariate.
For the categorical outcomes (eg, clinical test findings,
adverse events), logistic regression analysis was used, pre-
senting probability estimates with 95% CIs using the same
fixed effects and covariates as in the ANCOVA above. For
the categorical outcomes on self-reported data and adverse
events at week 12, data are presented as percentages, with
differences between groups determined by a chi-square test
or Fisher exact test.
For the longitudinal part of the trial (no imputation for
missing data needed), a linear mixed model with repeated
measures of the WOSI (weeks 4, 8, and 12) was performed
to test the difference and trajectory over time between the 2
groups (interaction: group  time) with the same fixed
effects and covariates as in the ANCOVA. For sensitivity
and exploratory purposes, per-protocol analysis was per-
formed, which included only the participants who had
acceptable exercise compliance.15
The study was powered to detect a difference of at least
250 points as the minimal clinically important difference
(MCID) between SINEX and HOMEX for the primary out-
come.28 To achieve 90% power to show a clinically relevant
between-group difference in favor of SINEX, with a 2-sided
type I error rate of 5%, 36 patients per group were
necessary.
All statistical analyses were performed with SPSS (Ver-
sion 24.0; IBM). P values <.05 (2-sided) were considered
statistically significant.
Patient Involvement
Patients with traumatic ASDs provided feedback about the
neuromuscular exercises during the development and
design of the SINEX program. After consenting to partici-
pate in the study, the patients were asked whether they
wanted to receive a letter explaining the results of this
trial. Accordingly, a letter in lay terms will be forwarded
to those interested when the study findings are published.
RESULTS
Participant Characteristics
A total of 130 patients were screened for eligibility. Of
these, 56 patients fulfilled the eligibility criteria, compris-
ing the ITT population (Figure 1), and were randomized to
either the SINEX or the HOMEX group. A total of 51 of 56
(93%) completed the 12-week follow-up assessment
(SINEX: n ¼ 27; HOMEX: n ¼ 24). At baseline, the groups
were comparable in demographics and clinical characteris-
tics (except for the WOSI lifestyle and NPRS within the
past 24 hours in which the HOMEX group had poorer
scores). The mean age was 25.8 ± 5.8 years and 26.2 ± 6.4
years for the HOMEX and SINEX groups, respectively, and
a majority of the patients were male (49/56; 88%). Baseline
characteristics are described in Tables 1 and 2.
For those returning diaries after completing the home
exercise (n ¼ 18 patients in each group), the overall adher-
ence was a mean of 71% for SINEX and 79% for HOMEX.
However, compliance with SINEX (at least 7/14 supervised
exercise sessions and at least 66% of the scheduled home-
based training) corresponded to 12 of 28 (43%) patients
attending a mean of 9 supervised sessions and 82% of the
scheduled home-based training. Compliance with HOMEX
(at least 66% of the scheduled home-based training) corre-
sponded to 15 of 28 (54%) patients performing a mean of
87% of the home-based training. Therefore, the per-protocol
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population was composed of 12 and 15 patients for the
SINEX and HOMEX groups, respectively.
Primary Outcome
The SINEX group had a significantly greater improvement
on the WOSI total, although marginally below the cutoff for
the MCID, compared with the HOMEX group in the change
from baseline to the 12-week follow-up (between-group
mean difference, –228.1 [95% CI, –430.5 to –25.6]; P ¼
.028) (Table 3). The mean change in the WOSI total score
was 655.3 (95% CI, 457.5 to 853.0) in the SINEX group and
427.2 (95% CI, 245.9 to 608.6) in the HOMEX group.
Secondary Outcomes
On 3 of 4 WOSI subdomains and in pain during the previ-
ous 7 days, significantly larger improvements were seen in
Lost to follow-up (n = 3)
- Unable to contact (n = 3) 
Lost to follow-up (n = 1)
- Unable to contact (n = 1) 
12-week follow up
Excluded (74)  
-Not meeting inclusion (49)
-Declined to participate (22)
- Logistics (17) 
- Already receiving other treatment (3) 
- Did not want to be randomized (2) 
-Other reasons (3) 
- Previous surgery in the opposite 
shoulder and not able to complete the 
shoulder exercise programs (1) 
- Unable to contact (2) 
Enrollment 
Assessed for eligibility (n = 130)
Randomized (n = 56)
Allocated to SINEX (n = 28)
• Received allocated intervention (n = 28)
Allocated to HOMEX (n = 28)
• Received allocated intervention (n = 28) 
Analyzed (n = 12)
Compliant with exercise protocol: 43%  
- Excluded from analysis (n = 16)
Analyzed (n = 15)
Compliant with exercise protocol: 54%  
- Excluded from analysis (n = 13)
Analyzed (n = 25)
- Excluded from analysis (n = 3)
Analyzed (n = 27)
- Excluded from analysis (n = 1)
As-observed analysis
Analyzed (n = 28)
- Excluded from analysis (n = 0)
Per-protocol analysis
Analyzed (n = 28)
- Excluded from analysis (n = 0)
Intention-to-treat analysis
Allocation 
Figure 1. Flowchart of participants with traumatic anterior shoulder dislocations (ASDs) in the study. A total of 49 patients did not
meet the inclusion criteria: 11 did not meet the age requirements (<18 years: n ¼ 5; >39 years: n ¼ 6), 11 had no radiographic
verification of a shoulder dislocation, 17 reported not having any problems with shoulder movements during daily activities in the
previous 7 days, 2 patients had a bony Bankart lesion or humeral head fracture, 1 patient had experienced more than 5 ASDs in his
or her lifetime, 2 patients had suspected competing diagnoses (sclerosis: n ¼ 1; unknown neurological disorder: n ¼ 1), 1 patient
was pregnant, 3 patients had no clinical signs of anterior shoulder instability, and 1 patient was not able to speak and write Danish.
HOMEX, self-managed, home-based, standard care shoulder exercise program; SINEX, nonsurgical, supervised, progressive
shoulder instability neuromuscular exercise.
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favor of the SINEX group (Table 3). Further significant
improvements in favor of SINEX were seen in clinical signs
of anterior shoulder instability with the apprehension test
and in CMS strength of the noninjured shoulder (Table 3).
Also, less than half of the patients (33% and 46%, respec-
tively) in the SINEX and HOMEX groups returned to pre-
injury levels of sport (Table 4). At the same time, the mean
ratings of actual shoulder function and ability to perform
sport/leisure activities on the GPE scale were rated
“improved” to “much improved,” with a statistically
significant difference in favor of the SINEX group com-
pared with the HOMEX group (6.2 vs 5.5 [P ¼ .012] and
5.8 vs 4.9 [P ¼ .025], respectively) (Table 4).
Although not statistically significant, only half of the
patients in the SINEX group (3/27; 11%) compared with the
HOMEX group (6/24; 25%) underwent or were referred for
shoulder stabilizing surgery (Table 4). In the multilevel
analyses, there was no difference between groups over time
for the WOSI total score and for each of the WOSI
TABLE 2
Baseline Outcome Measure Scoresa
SINEX
Group
(n ¼ 28)
HOMEX
Group
(n ¼ 28)
WOSI,b total (range, 0-2100) 970.2 ± 346.9 1145.5 ± 376.2
Physical symptoms (range,
0-1000)
351.8 ± 160.0 406.8 ± 206.2
Sport function (range, 0-400) 212.4 ± 83.4 259.8 ± 93.1
Lifestyle (range, 0-400) 205.2 ± 88.4 255.8 ± 86.0
Emotions (range, 0-300) 200.9 ± 62.4 223.1 ± 67.8
TSKb (range, 17-68) 43.3 ± 5.1 42.9 ± 4.0
High fear of movement and
reinjury (TSK 37), n (%)
26 (93) 26 (93)
Pain intensity for current shoulder
injuryb (range, 0-10)
Currently 2.4 ± 2.0 3.5 ± 2.5
Mean during past 24 h 2.6 ± 1.9 4.0 ± 2.1
Mean during previous 7 d 3.7 ± 1.8 4.6 ± 1.8
EQ-5D VASc (range, 0-100) 74.8 ± 15.5 73.7 ± 18.4
PSFSc (range, 0-10) 4.3 ± 2.5 4.5 ± 2.1
Generalized joint hypermobilityb
(range, 0-9; positive 5), n (%)
3 (11) 2 (7)
Positive clinical test findings, n (%)
Apprehension 28 (100) 26 (93)
Relocation 25 (89) 21 (75)
Surprise 23 (82) 22 (79)
CMS, totalc (range, 0-100) 72.6 ± 15.3 67.6 ± 20.7
Range of motionc (range, 0-40) 30.6 ± 8.0 28.0 ± 9.7
Strength,d kg
Injured shoulder 17.7 ± 6.8 18.1 ± 8.3
Noninjured shoulder 26.2 ± 7.4 25.8 ± 6.9
Shoulder JRS (mean absolute
error),e cm
Flexion 5.2 ± 6.2 5.5 ± 4.2
Abduction 5.5 ± 6.6 6.4 ± 4.8
aData are reported as mean ± SD unless stated otherwise. CMS,
Constant-Murley score; EQ-5D VAS, EuroQol 5-Dimensions ques-
tionnaire visual analog scale; HOMEX, self-managed, home-based,
standard care shoulder exercise program; JRS, joint reposition
sense; PSFS, Patient-Specific Functional Scale; SINEX, nonsurgi-
cal, supervised, progressive shoulder instability neuromuscular
exercise; TSK, Tampa Scale of Kinesiophobia; WOSI, Western
Ontario Shoulder Instability Index.
bHigher scores reflect worse status.
cLower scores indicate better status.
dIsometric shoulder strength at 90 of shoulder abduction in the
scapular plane with the use of a dynamometer.
eProprioceptive repositioning testing at 60 ± 10 of shoulder
flexion and abduction with the use of a laser beam.
TABLE 1
Baseline Demographic Informationa
SINEX
Group
(n ¼ 28)
HOMEX
Group
(n ¼ 28)
Male sex 26 (93) 23 (82)
Age, mean ± SD, y 26.2 ± 6.4 25.8 ± 5.8
Weight, mean ± SD, kg 86.0 ± 19.0 80.8 ± 13.4
Height, mean ± SD, cm 180.8 ± 8.0 178.3 ± 8.0
Educational level
University 7 (25) 10 (36)
College/technical school 12 (43) 12 (43)
Below high school 5 (18) 2 (7)
No formal education 4 (14) 4 (14)
Occupational status
Full-time employed 16 (57) 15 (54)
Part-time employed 2 (7) 0 (0)
Student 9 (32) 10 (36)
Unemployed/retired 0 (0) 0 (0)
On sick leave 1 (4) 3 (11)
Dominant arm, right 25 (89) 26 (93)
Injured shoulder, right 16 (57) 12 (43)
Injury mechanism
Fell on arm 13 (46) 15 (54)
Arm was pulled 4 (14) 3 (11)
External force to shoulder 2 (7) 1 (4)
Otherb 9 (32) 9 (32)
Traumatic anterior shoulder
dislocation(s) on injured side
1 18 (64) 19 (67)
2 3 (11) 7 (25)
3 4 (14) 1 (4)
4 2 (7) 1 (4)
5 1 (4) 0 (0)
Previous shoulder treatment(s) for
current shoulder injury
8 (29) 9 (32)
Exercise treatment 5 (18) 9 (32)
Passive treatment 1 (4) 1 (4)
Chiropractic 1 (4) 0 (0)
Analgesic medication (medically
prescribed)
2 (7) 4 (14)
Currently physically active 23 (82) 22 (79)
Physically active 4 h/wk 7 (25) 6 (21)
aData are reported as n (%) unless stated otherwise. HOMEX,
self-managed, home-based, standard care shoulder exercise pro-
gram; SINEX, nonsurgical, supervised, progressive shoulder insta-
bility neuromuscular exercise.
bDuring athletic activities (soccer, gymnastics, fun wrestling,
motocross).
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subdomain scores (baseline and weeks 4, 8, and 12), which
was only shown for the WOSI total (Figure 2).
Adverse Events
Few patients reported recurrent ASDs at the 12-week
follow-up, with no significant difference between groups
(Table 4). In addition, a large proportion (85% and 83%,
respectively) in the SINEX and HOMEX groups reported
“very little or not at all” on recurrent anterior shoulder insta-
bility or subluxations, with no significant difference between
groups (Table 4). Short-lasting adverse events at 12 weeks
were few, with no significant group differences (Table 5). The
most common adverse events were exercise-induced shoul-
der pain, soreness, and muscle fatigue (SINEX: n ¼ 10;
HOMEX: n ¼ 10).
Sensitivity and Per-Protocol Analyses
Patients who did and did not complete the follow-up assess-
ments (5 patients in total) did not differ on all baseline
variables (data not presented), except for employment now
in which those lost to follow-up had a lower rate of full-time
employment and a higher rate of sick leave. The per-
protocol analysis confirmed the ITT analysis, with further
significant group differences in favor of SINEX (data not
presented).
DISCUSSION
Although the MCID was not reached, this multicenter RCT
involving patients with traumatic ASDs showed the
TABLE 3
Changes in Outcome Measure Scores Between Baseline and Week 12 in Intention-to-Treat Populationa
Mean Change From Baseline
SINEX
Group (n ¼ 28)
HOMEX
Group (n ¼ 28)
Difference,
HOMEX vs SINEX P Value
WOSI,b total 655.3 (457.5 to 853.0) 427.2 (245.9 to 608.6) –228.1 (–430.5 to –25.6) .028
Physical symptoms 175.8 (112.8 to 238.8) 83.3 (18.1 to 148.6) –92.5 (–181.0 to –3.9) .041
Sport function 185.2 (139.5 to 230.9) 128.0 (87.3 to 168.1) –57.5 (–106.5 to –8.5) .022
Lifestyle 154.1 (109.2 to 199.0) 104.3 (67.7 to 144.9) –49.8 (–95.8 to –3.8) .034
Emotions 128.8 (89.4 to 168.3) 101.0 (66.1 to 136.0) –27.8 (–69.5 to 13.9) .187
TSKb 3.1 (1.3 to 4.8) 2.2 (0.4 to 4.0) 0.8 (–3.4 to 1.6) .485
High fear of movement and reinjury at baseline (TSK
37) and low fear of movement and reinjury at follow-
up (TSK <37), n (%)
9 (32.1) 6 (21.4) –10.7 (–43.2 to 15.9) .370
Pain intensity of current shoulder injuryb
Currently 2.4 (1.5 to 3.3) 1.9 (1.1 to 2.8) 0.5 (–1.4 to 0.5) .302
Mean in past 24 h 2.1 (1.1 to 3.2) 1.7 (0.8 to 2.7) –0.4 (–1.5 to 0.6) .453
Mean in previous 7 d 3.3 (2.4 to 4.3) 2.2 (1.4 to 3.1) –1.1 (–2.1 to –0.9) .033
EQ-5D VASc –13.9 (–20.4 to –7.4) –8.6 (–14.4 to –2.8) 5.3 (–1.6 to 12.1) .127
PSFSc –2.5 (–3.6 to 1.4) –1.3 (–2.5 to –0.2) 1.2 (–0.3 to 2.7) .124
Positive clinical test findings at baseline and negative
at follow-up, n (%)
Apprehension 18 (64.3) 8 (28.6) –35.7 (–62.2 to –9.6) .012
Relocation 14 (50.0) 8 (28.6) –21.4 (–49.3 to 4.4) .083
Surprise 15 (53.6) 10 (35.7) –17.9 (–44.4 to 8.3) .180
CMS, totalc –16.3 (–22.0 to –10.6) –13.0 (–18.9 to –7.2) 3.2 (–4.8 to 11.3) .427
Range of motionc –7.3 (–10.0 to –4.6) –3.5 (–6.2 to –0.8) 3.8 (–0.1 to 7.7) .057
Strength,d kg
Injured shoulder 2.5 (–5.5 to 0.5) 2.0 (–4.8 to 0.6) 0.5 (–2.5 to 3.4) .762
Noninjured shoulder 1.5 (0.6 to 2.4) 0.2 (–0.9 to 1.1) –1.3 (–2.6 to 0.0) .049
Shoulder JRS (mean absolute error),e cm
Flexion 2.2 (–0.2 to 4.6) 2.3 (0.1 to 4.5) 0.1 (–2.2 to 2.4) .921
Abduction 1.5 (–0.5 to 3.4) 0.4 (–1.7 to 2.4) –1.1 (–3.8 to 1.6) .422
aData are reported as mean (95% CI) unless stated otherwise. P values for continuous and dichotomous outcomes were calculated with
analysis of covariance and logistic regression, respectively, using treatment type, study center, sex, and injury status (primary or recurrent
anterior shoulder dislocation) as fixed effects and baseline values as covariates. Bolded P values indicate statistical significance. CMS,
Constant-Murley score; EQ-5D VAS, EuroQol 5-Dimensions questionnaire visual analog scale; HOMEX, self-managed, home-based, standard
care shoulder exercise program; JRS, joint reposition sense; PSFS, Patient-Specific Functional Scale; SINEX, nonsurgical, supervised,
progressive shoulder instability neuromuscular exercise; TSK, Tampa Scale of Kinesiophobia; WOSI, Western Ontario Shoulder Instability
Index.
bHigher scores reflect worse status.
cLower scores indicate better status.
dIsometric shoulder strength at 90 of shoulder abduction in the scapular plane with the use of a dynamometer.
eProprioceptive repositioning testing at 60 ± 10 of shoulder flexion and abduction with the use of a laser beam.
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superior effects of supervised neuromuscular shoulder exer-
cise versus standard care shoulder exercise after 12 weeks of
nonsurgical treatment with regard to the primary outcome
of patient-reported shoulder function and quality of life.
Further superior effects of SINEX were seen in a number
of key secondary outcomes, and although not statistically
significant, less than half of the patients in the SINEX group
(3/27) compared with the HOMEX group (6/24) underwent
or were referred for shoulder stabilizing surgery at the
12-week follow-up. Satisfaction with both exercise programs
was high, and no serious adverse events were reported.
We are not aware of any other RCTs investigating
the effectiveness of a nonsurgical, physical therapist–
supervised progressive exercise regimen in patients with
traumatic ASDs.25 Only 1 other study (noncontrolled cohort
study) has evaluated the effect of a 12-week nonsurgical
progressive shoulder rehabilitation program in patients
with traumatic ASDs (primary dislocations only).1 That
study found that 15 of 20 (75%) patients had no clinical sign
of anterior shoulder instability (negative apprehension test
finding),1 which is in line with the current results of 18 of 28
(64%) patients in the SINEX group. Regarding returning to
preinjury levels of sport, 15 of 20 (75%) patients in the study
by Aronen and Regan1 returned to unrestricted athletic
participation at the 12-week follow-up, which included the
sport that caused their initial dislocation. This is in con-
trast with the current findings in which a smaller propor-
tion of patients in both groups (SINEX, 9/27 [33%];
TABLE 4
Self-reported Data at 12-Week Follow-upa
SINEX Group
(n ¼ 27)
HOMEX Group
(n ¼ 24) P Value
Currently employed or a student .177
Yes 26 (96) 20 (83)
Yes, but on sick leave because of current shoulder injury 0 (0) 2 (8)
No, because of current shoulder injury 0 (0) 1 (4)
No, for reasons other than current shoulder injury 1 (4) 1 (4)
Time away from work/education because of current shoulder injury .184
None 20 (74) 12 (50)
1-9 d 2 (7) 7 (29)
10-24 d 3 (11) 2 (8)
25 d 2 (7) 3 (13)
Use of painkillers (<4 d/wk) because of current shoulder injury .503
None 24 (89) 23 (96)
1-4 pills/d 2 (7) 1 (4)
5-8 pills/d 1 (4) 0 (0)
Received other treatment(s)
No other treatment 24 (89) 21 (88) .865
Physical therapy 1 (4) 2 (8) .472
Corticosteroid injection 0 (0) 1 (4) .998
Massage 1 (4) 2 (8) .494
Other 1 (4) 2 (8) .494
Rated recurrent anterior shoulder dislocation(s) (yes) 3 (11) 2 (8) .999
Rated recurrent anterior shoulder instability or subluxation(s) (very little/not at all) 23 (85) 20 (83) .939
Rated extent of impact from actual shoulder injury on number of duties performed at work/
school within past 4 wk (very little/not at all)
22 (82) 21 (88) .600
Rated extent of impact from actual shoulder injury on quality of duties at work/school within
past 4 wk (very little/not at all)
22 (82) 20 (83) .738
Referred to or underwent shoulder stabilizing surgery (yes) 3 (11) 6 (25) .204
Rated actual shoulder condition as satisfying (to some extent/to a large degree) 22 (82) 18 (75) .609
Rated current shoulder exercise treatment to have failed (very little/not at all) 26 (96) 20 (83) .237
Desire to undergo shoulder surgery because of actual shoulder function .629
No 15 (56) 15 (65)
No, because of fear of surgery 6 (22) 2 (9)
Yes 6 (22) 6 (26)
Rated having returned to preinjury level of sport (to some extent/to a large degree) 9 (33) 11 (46) .240
Global perceived effect scale (range, 1-7; 7 ¼ very much improved), mean ± SD
Actual shoulder function 6.2 ± 0.3 5.5 ± 0.3 .012
Ability to perform activities of daily living 5.8 ± 0.3 5.2 ± 0.3 .051
Ability to perform sport/leisure activities 5.8 ± 0.4 4.9 ± 0.4 .025
Shoulder-related quality of life 5.4 ± 0.3 4.8 ± 0.3 .125
aData are reported as n (%) unless stated otherwise. Bolded P values indicate statistical significance. HOMEX, self-managed, home-based,
standard care shoulder exercise program; SINEX, nonsurgical, supervised, progressive shoulder instability neuromuscular exercise.
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HOMEX, 11/24 [46%]) returned to their preinjury level of
sport at the 12-week follow-up. One explanation for this
discrepancy may be the difference in populations (occupa-
tional1 vs general and not necessarily athletic population
[no sport to return to] and first-time1 vs first-time or recur-
rent ASD). Another reason may be the different definitions
of return to sport (“being allowed to participate in unre-
stricted athletic participation”1 and “returning to preinjury
level of sport”). Nonetheless, the superior benefit of SINEX
in the current study was further consistent with the results
of the GPE scale in which the mean rating (7-point Likert
scale; 7 ¼ best) for capability to perform sport/leisure activ-
ities was higher in the SINEX group than in the HOMEX
group (5.8 vs 4.9, respectively; P ¼ .025) at the 12-week
follow-up. This corresponds to “much improved” from only
“improved.” Thereby, the current results seem to reflect the
conclusion of Aronen and Regan, stating “that a progressive
neuromuscular program substantially improves the likeli-
hood of full return to activity.”
In agreement with the hypothesis, the SINEX program
with supervised physical therapy guidance in neuromuscu-
lar shoulder exercises had a larger effect compared with the
HOMEX program and was safe to perform. However, with
the 95% CI of the primary outcome including the cutoff of
250 points for the WOSI, prespecified as a clinically rele-
vant MCID, a true between-group difference in favor of
SINEX cannot be ruled out. However, while previous stud-
ies have recommended changes ranging from 210 to 400 of
2100 (10%-19%) for the WOSI total score,6,28,46 one might
question the current MCID threshold, as it is at the lower
end of the suggested changes (228.1). However, despite the
fact that both groups were expected to improve, regardless
of treatment allocation, a large between-group treatment
effect (eg, MCID of 400/2100 [19%]) was not anticipated .
Thus, the current MCID of at least 250 of 2100 (12%) points
for the WOSI total was pragmatically chosen based on the
existing literature and within the common rule of thumb of
a minimum of 10% difference for interpreting MCIDs in
Figure 2. Western Ontario Shoulder Instability (WOSI) total
score at baseline and weeks 4, 8, and 12 for the SINEX versus
HOMEX groups among patients with traumatic anterior shoul-
der dislocations. The graphs illustrate the results from the
intention-to-treat population. Data points represent least
squares means. (A) Nonresponder imputation (SINEX, n ¼
28; HOMEX, n ¼ 28). (B) As observed (SINEX, n ¼ 28, 26,
18, and 27, respectively; HOMEX, n ¼ 28, 25, 22, and 25,
respectively). (C) Per-protocol analysis (SINEX, n ¼ 12, 10,
10, and 12, respectively; HOMEX, n ¼ 15, 14, 15, and 15,
respectively). HOMEX, self-managed, home-based, standard
care shoulder exercise program; SINEX, nonsurgical, super-
vised, progressive shoulder instability neuromuscular exercise.
TABLE 5
Adverse Events From Baseline to Week 12a
SINEX
Group
(n ¼ 27)
HOMEX
Group
(n ¼ 23) P
Issues related to shoulder because of
shoulder exercise program
Pain 3 (11) 2 (9) .766
Soreness 6 (22) 4 (17) .651
Muscle fatigue 1 (4) 4 (17) .130
Other (eg, skin irritation) 1 (4) 1 (4) .882
At least 1 of the above 8 (30) 8 (35) .668
Sought health care from general
practitioner because of shoulder-
related issues
2 (7) 1 (4) .773
Sought health care from orthopaedic
surgeon because of shoulder-related
issues
0 (0) 2 (9) .998
Issues related to other body parts
because of shoulder exercise program
3 (11) 4 (17) .335
aData are reported as n (%). Includes any specific and serious
adverse events. P values were calculated with the Fisher exact
test. HOMEX, self-managed, home-based, standard care shoulder
exercise program; SINEX, nonsurgical, supervised, progressive
shoulder instability neuromuscular exercise.
The Orthopaedic Journal of Sports Medicine Exercise Treatment for Traumatic ASDs 9
patient-reported outcomes.39 Furthermore, most of the sec-
ondary patient-reported outcome measures supported the
primary finding in the current study but not the objective
outcome measures of the CMS and JRS. The reason may be
that the CMS is not specifically designed to evaluate shoul-
der instability48 and that JRS testing, for reliability rea-
sons,45 was performed in low-range positions only (<60
of shoulder flexion/abduction), thus not able to capture the
proprioceptive changes achieved during the SINEX pro-
gram predominantly including overhead exercises.
Finally, it should be noted that the long-term effects
regarding preventing recurrent ASDs, avoiding surgery, and
returning to sport, among others, of the current treatments
are unknown. In addition, it is unknown how much added
cost attributed to physical therapy there is associated with
administering SINEX, but a long-term follow-up at 1 and 2
years and cost-benefit analysis will be performed.
Limitations and Strengths
Although the sample size and adherence were relatively
low, which increased the risk of type II errors, the current
data showed a significant and nearly clinically relevant
difference in favor of SINEX. To further support these find-
ings, both the sensitivity and per-protocol analyses con-
firmed the current ITT analysis.
Another limitation is that the number of glenohumeral
Hill-Sachs lesions and anterior bone loss in each group are
unknown. However, the nature of the randomized design
ensures that these characteristics were equally distributed
between the 2 groups, thereby limiting any potential bias.
Also, the decision to enroll patients with primary as well as
recurrent ASDs may seem controversial, as they may have
had different starting points for treatment. However, a
recent cross-sectional analysis revealed that patients with
primary and recurrent ASDs present with equally poor
shoulder function and a high fear of reinjuries, thereby
indicating equal indications for receiving treatment regard-
less of the number of previous dislocations.16 Furthermore,
although stratification may be seen as a limitation, the use
of this technique ensured that the number of patients with
primary and recurrent ASDs were equally distributed
between the 2 groups, thereby limiting any potential bias.
In some countries, it may be that a home-based program is
not the standard care for patients with traumatic ASDs,
which is why the generalizability of the current findings may
be limited. However, the current HOMEX program was
designed to reflect the core similarity of standard care
packages across most hospitals in Denmark. Because of the
design, it was not possible to blind the patients and the
treating physical therapists; yet, because all outcome assess-
ments and analyses of the primary outcome were performed
blinded and all WOSI scores showed a consistent pattern in
favor of SINEX, this is not considered a major limitation.
It is also a limitation that we cannot conclude whether it
is the neuromuscular aspect, the difference in supervision,
or a combination of the two that makes up the current
treatment effect. Finally, because of technical errors having
wrongly allocated 2 patients in the analysis performed after
the consensus agreement on blinded data interpretation
(see Appendix 4, available as supplemental material), these
data could not be used entirely as intended. However, the
revised analysis further confirmed the findings in the
blinded interpretation document, and the topics suggested
as points for discussion in the consensus agreement could
still be used.
One strength of this study is the detailed and published
protocol including blinded analysis and interpretation of the
primary outcome. Furthermore, this study developed and
used a standardized, individualized, physical therapist–
supervised neuromuscular shoulder exercise program
targeting both primary and recurrent ASDs. This study
therefore complies with recent recommendations for further
research, pointing to the need for more studies to refine an
ideal physical therapy regimen for nonsurgical manage-
ment after primary and recurrent ASDs.25
Another strength is that only 2 outcome examiners were
used, which is why assessment variability was kept to a
minimum for the objectively measured outcomes. Also, the
rate of loss to follow-up was low and equal in both groups.
Finally, it is a strength that the control group (HOMEX)
received a realistic and active treatment approach that is
often used today and expected to induce a true treatment
effect. Still, SINEX managed to improve patients more.
CONCLUSION
Ultimately, 12 weeks of neuromuscular shoulder exercise
(SINEX) was superior to a standard care home exercise
program (HOMEX) in improving patient-reported shoulder
function in patients with traumatic ASDs, although the
improvement did not reach the MCID. As SINEX showed
the most benefit, this exercise program could potentially be
the first-choice option in patients with traumatic ASDs who
are not candidates for early shoulder stabilizing surgery.
Further long-term treatment effects on patient-reported
outcomes and shoulder redislocations as well as socioeco-
nomic evaluations of SINEX are needed to explore the
potential for nonsurgical rehabilitation of this complex
patient group.
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